Loading...
XSHE
300246
Market cap581mUSD
Jul 10, Last price  
15.07CNY
1D
1.07%
1Q
3.93%
Jan 2017
-32.21%
IPO
105.31%
Name

Guangdong Biolight Meditech Co Ltd

Chart & Performance

D1W1MN
XSHE:300246 chart
P/E
—
P/S
3.64
EPS
—
Div Yield, %
0.34%
Shrs. gr., 5y
3.84%
Rev. gr., 5y
0.08%
Revenues
1.10b
+3.29%
86,314,031103,443,225143,634,086158,103,676182,285,238234,831,957288,993,463380,505,474594,314,415711,472,878813,385,393825,961,0941,396,013,5711,091,018,4341,091,018,4341,183,699,6801,183,699,6791,194,001,1291,060,481,1971,095,390,747
Net income
-69m
L-2.82%
10,564,21920,405,07332,991,28933,775,32036,505,94028,923,72533,801,50523,919,00067,143,47557,547,29164,193,40564,712,766346,147,55563,792,59563,792,59822,132,61222,132,615-65,185,124-71,441,311-69,427,752
CFO
90m
P
12,675,16517,193,52540,087,80829,057,31240,515,47427,320,09742,310,64028,397,76050,805,21472,306,09181,207,34781,425,906455,780,88480,613,715140,721,997129,047,347-8,636,42090,442,530
Dividend
Nov 26, 20250.05 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Guangdong Biolight Meditech Co., Ltd., founded in 1993 and headquartered in Zhuhai, China, operates as a global enterprise. The company is dedicated to the full spectrum of medical technology, encompassing the research, development, commercialization, sales, and after-sales service of various medical devices, consumables, and integrated healthcare solutions. Its extensive product portfolio includes patient and fetal monitors, ECG machines, hemodialysis equipment, homecare medical products, and specialized items such as medical pumps and veterinary monitors, along with related accessories. Biolight Meditech maintains a broad international footprint, delivering its offerings to markets across Asia, Africa, Europe, North America, and Latin America.
URL
http://www.blt.com.cn
IPO date
Jul 19, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT